Anti-Niemann Pick C1 Single-Stranded Oligonucleotides with Locked Nucleic Acids Potently Reduce Ebola Virus Infection In Vitro
Ebola virus is the causative agent of Ebola virus disease, a severe, often fatal illness in humans. So far, there are no US Food and Drug Administration (FDA)-approved therapeutics directed against Ebola virus. Here, we selected the host factor Niemann-Pick C1 (NPC1), which has been shown to be esse...
Main Authors: | Anne Sadewasser, Erik Dietzel, Sven Michel, Michael Klüver, Markus Helfer, Tamara Thelemann, Richard Klar, Markus Eickmann, Stephan Becker, Frank Jaschinski |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-06-01
|
Series: | Molecular Therapy: Nucleic Acids |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2162253119300915 |
Similar Items
-
Liver-Targeted Anti-HBV Single-Stranded Oligonucleotides with Locked Nucleic Acid Potently Reduce HBV Gene Expression In Vivo
by: Hassan Javanbakht, et al.
Published: (2018-06-01) -
Niemann-Pick C1 Is Essential for Ebola Virus Infection and a Target of Small Molecule Inhibitors
by: Bruchez, Anna
Published: (2012) -
Multiple cationic amphiphiles induce a Niemann-Pick C phenotype and inhibit Ebola virus entry and infection.
by: Charles J Shoemaker, et al.
Published: (2013-01-01) -
Risk Prediction for Niemann-Pick Disease
by: J Gordon Millichap
Published: (2012-06-01) -
Niemann-Pick Disease Type C
by: J Gordon Millichap
Published: (1989-09-01)